Chest symptoms after sumatriptan: A two-year clinical practice review in 735 consecutive migraine patients

Cephalalgia

Volumn 16, Issue 8, 1996, Pages 554-559

  Visser, W H ^a   Jaspers, N M W H ^a   De Vriend, R H M ^a   Ferrari, M D ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

acute treatment of migraine; adverse events; chest symptoms; migraine; safety; sumatriptan

Indexed keywords

SUMATRIPTAN;

ADULT; ARTICLE; DRUG SAFETY; FEMALE; HUMAN; INCIDENCE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MIGRAINE; ORAL DRUG ADMINISTRATION; RISK FACTOR; SUBCUTANEOUS DRUG ADMINISTRATION; SYMPTOMATOLOGY; THORAX DISEASE; THORAX PAIN;

ADULT; ANGINA PECTORIS; CHEST PAIN; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; RETROSPECTIVE STUDIES; RISK FACTORS; SEROTONIN AGONISTS; SUMATRIPTAN; VASOCONSTRICTOR AGENTS;

EID: 0030473835     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1996.1608554.x     Document Type: Article

References (44)

1. Plosker GL, McTavish D. Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs 1994;47(4):622-51
2. Brown EG, Endersby CA, Smith RN, Talbot JCC. The safety and tolerability of sumatriptan: an overview. Eur Neurol 191;31:339-44
3. Abrahamsen B, Christiansen BD. Angina pectoris after administration of sumatriptan. Ugeskr Laeger 1992;154:3602-3
4. Castle WM, Simmons VE. Coronary vasospasm and sumatriptan. Br Med J 1992;305:117-8
5. Curtin Th, Brooks AP, Roberts JA. Cardiorespiratory distress after sumatriptan given by injection. Br Med J 1992;305:713-4
6. Willet F, Curzen N, Adams J, Armitage M. Coronary vasospasm induced by subcutaneous sumatriptan. Br Med J 1992;304:1415
7. Ottervanger JP, Paalman HJA, Boxma GL, Stricker BHC. Transmural myocardial infarction with sumatriptan. Lancet 1993;341:861-2
8. Boyd IW, Rohan AP. Sumatriptan-induced chest pain. Lancet 1994;344:1704-5
9. O'Connor P, Gladstone P. Oral sumatriptan associated transmural myocardial infarction. Neurology 1995;45(12):2274-6
10. Kelly KM. Cardiac arrest following use of sumatriptan. Neurology 1995;45:1211-3
11. Chester AH, Martin GR, Bodelsson M, Arneklo-Nobin B, Tadjkarimi S, Tornebrandt K, Yacoub MH. 5-Hydroxytryptamine receptor profile in healthy and diseased human epicardial coronary arteries. Cardiovasc Res 1990;24:932-7
12. Saxena PR, Villalón CM. 5-Hydroxytryptamine: a chameleon in the heart. Trends Pharmacol Sci 1991;12:223-7
13. MacFadden EP, Clarke JG, Davies GJ, Kaski JC, Haider AW, Maseri A. Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. N Engl J Med 1991;3254:648-54
14. Myerburg RJ, Kessler KM, Mallon SM, Cox MM, deMarchena E, Interian A, Castellanos A. Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary artery spasm. N Engl J Med 1992;326:1451-5
15. 1-receptor agonist on cerebral hemodynamics and the coronary circulation. Br J Clin Pharmacol 1992;34:541-6
16. 1 agonist, on the systemic, pulmonary, and coronary circulation. Circulation 1993;87:401-5
17. Bax WA, Renzenbrink GJ, Heuven-Nolsen van D, Thijssen EJM, Bos E, Saxena PR. 5HT receptors mediating contractions of the isolated human coronary artery. Eur J Pharmacol 1993;239:203-10
18. Golino P, Piscione F, Willerson JT, Cappelli-Bigazzi M, Focaccio A, Villari B, et al. Divergent effects of serotonin on coronary artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. N Engl J Med 1991;324:641-8
19. Golino P, Massen A. Serotonin receptors in human coronary arteries. Circulation 1994;3:1573-5
20. Pilgrim AJ, Stewart-Long P, Fowler PA. Intensive ECG surveillance in patients receiving sumatriptan after previous chest symptoms. Cephalalgia 1993:13 Suppl 13:167
21. Hillis WS, MacIntyre PD. Sumatriptan and chest pain. Lancet 1993;341:1564-5
22. Evers S, Husstedt I-W, Engbergs A. Coronary angiography in migraine patients after subcutaneous sumatriptan. Lancet 1995;345:198
23. Visser WH, Vriend RHM de, Jaspers NMWH, Ferrari MD. Sumatriptan in clinical practice; a two year review of 453 migraine patients. Neurology 1996;47(1):46-51
24. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8 Suppl 7:1-96
25. Ferrari MD, Saxena PR. Clinical and experimental effects of sumatriptan in humans. Trends Pharmacol Sci 1993;14:129-33
26. Lipton RB, Silberstein SD, Stewart WF. An update on the epidemiology of migraine. Headache 1994;34:319-28
27. Lipton RB, Stewart WF. The epidemiology of migraine. Eur Neurol 1994;34 Suppl 2:6-11
28. Rasmussen BK, Breslau N. Epidemiology. In: Olesen J, Tfelt-Hansen P, Welch KMA, editors. The headaches. New York: Raven Press 1993:169-73
29. Dahlöf C, Ekbom K, Persson L. Clinical experiences from Sweden on the use of subcutaneously administered sumatriptan in migraine and cluster headache. Arch Neurol 1994;51:1256-61
30. Sheftell FD, Weeks RE, Rapoport AM, Siegel S, Baskin S, Arrowsmith F. Subcutaneous sumatriptan in a clinical setting: the first 100 consecutive patients with acute migraine in a tertiary care center. Headache 1994;34:67-72
31. Ottervanger JP, Van Witsen TB, Valkenburg HA, et al. Adverse reactions attributed to sumatriptan: a post-marketing study in general practice. Eur J Clin Pharmacol 1994;47:305-9
32. Ottervanger JP, Stricker BH. Cardiovascular adverse reactions to sumatriptan. Cause for concern? CNS Drugs 1995;3(2):90-8
33. Tansey MJB, Pilgrim AJ, Martin PM. Long-term experience with sumatriptan in the acute treatment of migraine. Eur Neurol 1993;33:310-15
34. Lloyd K. The clinical profile of sumatriptan: safety and tolerability. Eur Neurol 1994;34 Suppl 2:40-3
35. Rapaport E. Angina and oesophageal pain. Eur Heart J 1986;7:824-7
36. Janssens J, Vantrappen G. Angina-like chest pain of oesophageal origin. In: Ballière's Clin Gastroenterol 1987;1:843-55
37. Houghton LA, Foster JM, Whorwell PJ, Morris J, Fowler P. Is chest pain after sumatriptan oesophageal in origin? Lancet 1994;344:985-6
38. Epstein SE, Gerber LH, Borer JS. Chest wall syndrome. A common cause of unexpected cardiac pain. JAMA 1979;241:2793-7
39. Inman W, Kubota K. Cardiorespiratory distress after sumatriptan given by injection (letter). Br Med J 1992;305:714
40. Lloyd DK, Pilgrim AJ. The safety of sumatriptan in asthmatic migraineurs. Cephalalgia 1993;13:201-4
41. Blau JN. Resolution of migraine attacks: sleep and the recovery phase. J Neurol Neurosurg 1982;45:223-6
42. Scott AK. Sumatriptan. Clin Pharmacokinet 1994;27(5):337-44
43. Fowler PA, Lacey LF, Thomas M, Keene ON, Tanner RJN, Baber NS. The clinical pharmacology, pharmacokinetics and metabolism of sumatriptan. Eur Neurol 1991;31:291-4
44. 1 receptors in migraine pathophysiology and treatment. Eur J Neurol 1995;2:5-21